Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

    Not recruiting

    1 1 1
    Investigated diseases:
    Sweden
  • Study on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    1 1
    Investigated drugs:
    Germany Poland
  • Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Bulgaria Denmark France Germany +5
  • Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

    Not recruiting

    1 1 1
    Investigated diseases:
    Bulgaria Czechia Denmark Germany Greece Hungary +6
  • Study of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer

    Not recruiting

    1 1 1
    France Italy Spain
  • Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

    Not recruiting

    Investigated diseases:
    Austria Bulgaria Germany Ireland Italy Poland
  • Study of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer

    Not recruiting

    1 1 1
    France Germany Italy The Netherlands Spain
  • Study of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1
    Belgium France Germany Italy Poland Spain
  • Study of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • Study of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy

    Not recruiting

    1 1 1
    Investigated diseases:
    France